BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23326386)

  • 1. Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel.
    Valencia CA; Ankala A; Rhodenizer D; Bhide S; Littlejohn MR; Keong LM; Rutkowski A; Sparks S; Bonnemann C; Hegde M
    PLoS One; 2013; 8(1):e53083. PubMed ID: 23326386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy.
    Valencia CA; Rhodenizer D; Bhide S; Chin E; Littlejohn MR; Keong LM; Rutkowski A; Bonnemann C; Hegde M
    J Mol Diagn; 2012; 14(3):233-46. PubMed ID: 22426012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of targeted capture technology and next generation sequencing in molecular diagnosis of inherited myopathy].
    Fu X; Liu A; Yang H; Wei C; Ding J; Wang S; Wang J; Yuan Y; Jiang Y; Xiong H
    Zhonghua Er Ke Za Zhi; 2015 Oct; 53(10):741-6. PubMed ID: 26758109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation.
    Jones MA; Bhide S; Chin E; Ng BG; Rhodenizer D; Zhang VW; Sun JJ; Tanner A; Freeze HH; Hegde MR
    Genet Med; 2011 Nov; 13(11):921-32. PubMed ID: 21811164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying next generation sequencing with microdroplet PCR to determine the disease-causing mutations in retinal dystrophies.
    Wang X; Zein WM; D'Souza L; Roberson C; Wetherby K; He H; Villarta A; Turriff A; Johnson KR; Fann YC
    BMC Ophthalmol; 2017 Aug; 17(1):157. PubMed ID: 28838317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan.
    Liang WC; Tian X; Yuo CY; Chen WZ; Kan TM; Su YN; Nishino I; Wong LC; Jong YJ
    PLoS One; 2017; 12(2):e0170517. PubMed ID: 28182637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing of the
    Aravind S; Ashley B; Mannan A; Ganapathy A; Ramesh K; Ramachandran A; Nongthomba U; Shastry A
    Indian J Med Res; 2019 Sep; 150(3):282-289. PubMed ID: 31719299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.
    Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX
    Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and etiology of congenital muscular dystrophy: We are halfway there.
    O'Grady GL; Lek M; Lamande SR; Waddell L; Oates EC; Punetha J; Ghaoui R; Sandaradura SA; Best H; Kaur S; Davis M; Laing NG; Muntoni F; Hoffman E; MacArthur DG; Clarke NF; Cooper S; North K
    Ann Neurol; 2016 Jul; 80(1):101-11. PubMed ID: 27159402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing using microfluidic PCR enrichment for molecular autopsy.
    Raju H; Ware JS; Skinner JR; Hedley PL; Arno G; Love DR; van der Werf C; Tfelt-Hansen J; Winkel BG; Cohen MC; Li X; John S; Sharma S; Jeffery S; Wilde AAM; Christiansen M; Sheppard MN; Behr ER
    BMC Cardiovasc Disord; 2019 Jul; 19(1):174. PubMed ID: 31337358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.
    Ware JS; John S; Roberts AM; Buchan R; Gong S; Peters NS; Robinson DO; Lucassen A; Behr ER; Cook SA
    J Cardiovasc Transl Res; 2013 Feb; 6(1):94-103. PubMed ID: 22956155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Single Gene Analyses Beyond Sanger.
    Najm J; Rath M; Schröder W; Felbor U
    Hamostaseologie; 2018 Aug; 38(3):158-165. PubMed ID: 30261521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain.
    Gonzalez-Quereda L; Rodriguez MJ; Diaz-Manera J; Alonso-Perez J; Gallardo E; Nascimento A; Ortez C; Natera-de Benito D; Olive M; Gonzalez-Mera L; Munain AL; Zulaica M; Poza JJ; Jerico I; Torne L; Riera P; Milisenda J; Sanchez A; Garrabou G; Llano I; Madruga-Garrido M; Gallano P
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.
    Cheng DT; Cheng J; Mitchell TN; Syed A; Zehir A; Mensah NYT; Oultache A; Nafa K; Levine RL; Arcila ME; Berger MF; Hedvat CV
    J Mol Diagn; 2014 Sep; 16(5):504-518. PubMed ID: 25017477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders.
    Guzel F; Romano M; Keles E; Piskin D; Ozen S; Poyrazoglu H; Kasapcopur O; Demirkaya E
    Front Immunol; 2021; 12():666273. PubMed ID: 34177904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
    Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
    J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.